Search results
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 4 days agoThe U.S. Food and Drug Administration (FDA) is set to convene a Medical Device Advisory Committee...
Will AI replace doctors who read X-rays, or just make them better than ever?
Denver Post· 14 hours agoThe need for such technology in Europe is urgent, with some hospitals facing...sells an AI tool for...
Study identifies potential pathway to reducing breast cancer brain metastases
Medical Xpress· 1 day agoBy studying the metabolic differences between primary breast cancer cells and those that metastasize to the brain, they determined that autophagy was significantly ...
Sana Al Sukhun, MD, on Metastatic Breast Cancer Treatment in Lower-Income Settings
MedPage Today· 4 days agoTreatment guidelines for patients with metastatic breast cancer often recommend tests, drugs, and...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 3 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 6 days ago“There’s been an explosion of these agents over the past couple of years and we have a ton of them...
ASCO 2024: Precede Biosciences assay classifies HER2 and ER status in cancers
Clinical Trials Arena via Yahoo Finance· 5 days agoWhile other cancer blood tests have focused on identifying individual tumour-associated mutations,...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe current standard of care in the first line is a combination of Genentech...and Perjeta has been...
Eli Lilly Is Trading At A Record High Ahead Of A Key FDA Meeting — Is It A Buy?
Investor's Business Daily· 1 day agoLilly is also planning to ask the FDA to approve tirzepatide in patients with obstructive sleep...
UCLA oncologist Dr. Dennis Slamon awarded Szent-Gy | Newswise
Newswise· 4 days agoDr. Dennis Slamon, a world-renowned oncologist and scientist whose groundbreaking research has...